UFP TECHNOLOGIES INC — Form 8-K
Filed August 3, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 42/100
What the filing says
UFP Technologies reported Q2 2026 net sales of $174.0M (up 15.1% YoY from $151.2M), net income of $20.9M (up 21.4% from $17.2M), and diluted EPS of $2.68 GAAP/$2.92 adjusted (vs. $2.21/$2.50 prior year). Six-month results: $328.2M sales (up 9.6%), $38.3M net income (up 11.6%), $4.92/$5.39 diluted EPS. Gross margin improved to 29.3% from 28.8%. CEO cited 14.7% growth from top-five customers and 19.7% from other MedTech business, though Dominican Republic investments create near-term margin pressure.
Why this rating
Strong earnings beat and organic growth (12.4% Q2, 6.8% H1) are positive, but event is routine quarterly disclosure. Relative to ~$1.8B market cap, $20.9M quarterly net income (~4.6% annualized run-rate) and incremental growth rates represent solid but not transformational execution. No material M&A, guidance change, or strategic shift disclosed.
See more from August 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.